Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from cyclosporine to tacrolimus with C0 vs Bayesian C4 monitoring after liver transplantation
2008-000627-26Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- May 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tacrolimus in chronic kidney disease (CKD) and hypertension (HTN) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Change in renal function. Started May 2008; status: active.
02
Drugs
tacrolimus
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on 2008-000627-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000627-26.